Sumitomo Mitsui Trust Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.6M | Buy |
|
|||||
|
2025
Q1 | $25.6M | Sell |
|
|||||
|
2024
Q4 | $31.8M | Buy |
|
|||||
|
2024
Q3 | $26.7M | Sell |
|
|||||
|
2024
Q2 | $33.5M | Sell |
|
|||||
|
2024
Q1 | $34.8M | Buy |
|
|||||
|
2023
Q4 | $32.1M | Buy |
|
|||||
|
2023
Q3 | $26M | Sell |
|
|||||
|
2023
Q2 | $22.9M | Sell |
|
|||||
|
2023
Q1 | $28.8M | Buy |
|
|||||
|
2022
Q4 | $33.9M | Sell |
|
|||||
|
2022
Q3 | $30.2M | Buy |
|
|||||
|
2022
Q2 | $27.6M | Buy |
|
|||||
|
2022
Q1 | $26.2M | Sell |
|
|||||
|
2021
Q4 | $25.1M | Buy |
|
|||||
|
2021
Q3 | $25.4M | Sell |
|
|||||
|
2021
Q2 | $26.3M | Sell |
|
|||||
|
2021
Q1 | $29.7M | Sell |
|
|||||
|
2020
Q4 | $29.4M | Sell |
|
|||||
|
2020
Q3 | $32.6M | Sell |
|
|||||
|
2020
Q2 | $52M | Sell |
|
|||||
|
2020
Q1 | $47.9M | Buy |
|
|||||
|
2019
Q4 | $32M | Buy |
|